Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Virginia for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Virginia only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Virginia (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Waqas Ilyas (NPI 1467482984)

Field	Value
Entity Type	Individual
Organization	Waqas Ilyas
Address	347 Westside Station Dr
City	Winchester
State	VA
ZIP	22601
Taxonomy	Ophthalmology Physician
NPI Enumerated	July 3, 2006

Payer Source	Total Paid
Medicare	$3M
Medicaid	$0

Key Findings

This provider is functionally a retina-focused ophthalmology practice whose Medicare revenue is driven by intravitreal drug therapy and associated procedures. The top three Medicare codes — J0178 (46.2%), J2777 (25.0%), and 67028 (7.4%) — together account for 78.6% of the provider's Medicare revenue, and the presence of high-volume injection codes alongside OCT/imaging codes (92134, 92250) indicates routine, office-based treatment and monitoring of retinal disease. Total Medicare revenue is $3M, and there is no Medicaid billing on file, so the business model appears concentrated on fee-for-service Medicare retinal care.

Revenue concentration is high and concentrated in drug/injection services: J0178 alone represents 46.2% of Medicare revenue and J2777 another 25.0%, meaning nearly three-quarters of revenue comes from two intravitreal drug codes. That concentration implies sensitivity of this provider’s topline to changes in Medicare drug reimbursement, utilization management, or shifts in preferred agents.

The practice’s operational footprint is consistent with high-volume intravitreal injection throughput: large claim counts for J0178 (2.2K claims) and J2777 (27.3K claims) coupled with 67028 (2.3K claims) and frequent diagnostic imaging (92134 at 3.2K claims) indicate repeated visit cycles for chronic retinal conditions such as wet AMD or neovascular disease. These service-line signals — drug injections plus retinal imaging and E/M visits — align with a treatment-and-monitor model rather than primarily surgical ophthalmology.

Competitive standing by national ranks is mixed: for high-revenue injection codes the provider is a prominent but not dominant national participant — J0178 ranks #463 of 3204 providers (86th percentile, described as typical/unremarkable volume) and J2777 ranks #339 of 2039 (83th percentile, typical/unremarkable volume). By contrast, the intravitreal procedure code 67028 ranks #242 of 4255 (94th percentile) and is described as notably above typical national volume, showing above-average procedural activity relative to peers.

Several services are statistical outliers in national comparisons, suggesting exceptionally high utilization in specific areas. Office/outpatient E/M code 99214 ranks #6058 of 479517 (99th percentile) and is labeled an "extreme outlier, far above typical national volume," and retinal imaging 92134 also ranks in the 99th percentile and is similarly labeled an "extreme outlier, far above typical national volume," both indicating unusually high visit and imaging volumes per Medicare benchmarks.

The provider bills a mix of anti-VEGF and newer intravitreal agents, reflecting adoption of multiple pharmacologic options: J0178 (aflibercept), J2777 (faricimab), J2781 (pegcetacoplan) and J9035 (bevacizumab) all appear in the top codes. Several of these codes (J2781 ranks #54 of 490, 89th percentile; J9035 ranks #85 of 1852, 95th percentile) show above-typical participation for newer or lower-cost alternatives, signaling a diversified drug utilization profile within retinal therapeutics.

Payer mix is effectively single-payer Medicare for the available data: total Medicare revenue is $3M while the dataset shows "none below" for Medicaid, meaning no Medicaid billing on file. That concentration simplifies reimbursement exposure to Medicare policy and population trends but also increases vulnerability to Medicare-specific payment and utilization changes.

The provider has an established enrollment history with an NPI enumerated date of 2006-07-03 (~20 years ago), indicating long-standing participation in Medicare. This tenure, combined with the high percentiles on key procedure and imaging codes, suggests an experienced retinal practice with sustained Medicare volume rather than a newly established entrant.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

18 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,160	$650	$1.4M
J2777	Injection, faricimab‑svoa, 0.1 mg	27,340	$30	$765.4K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	2,330	$100	$225.8K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	1,450	$120	$174.5K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,270	$80	$106.8K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	3,160	$30	$91.7K
J3490	Unclassified drugs	80	$1,090	$91.2K
J2778	Injection, ranibizumab, 0.1 mg	420	$150	$60.3K
J9035	Injection, bevacizumab, 10 mg	970	$60	$53.2K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	190	$110	$20.7K

Showing 1–10 of 18

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 18 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Virginia Distribution

Waqas Ilyas — 3 of 18 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Virginia

Full comparison — all codes billed, vs. state median

18 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	26	80	1,400	$690	$1.1M
J2777	14	60	13,200	$30	$517.1K
J2778	27	40	560	$180	$171.5K
67028	10	90	1,000	$90	$107.1K
J2781	2	20	560	$120	$86.6K
92014	510	870	170	$80	$32.8K
99214	208	12,890	140	$80	$21K
J3490	28	110	60	$280	$20.5K
J9035	5	60	170	$50	$19.9K
99213	2,151	12,440	90	$60	$10K

Showing 1–10 of 18

Related Providers

Other providers that share a Tax Identification Number (TIN) with Waqas Ilyas, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
David Warrow	MD	Ophthalmology Physician	$15.1M	$8.3K
Navid Moradshahi	CA	Diagnostic Radiology Physician	$1.2M	$0
John Minarcik	VA	Retina Specialist (Ophthalmology) Physician	$913.4K	$0
Walter Osias	CA	Diagnostic Radiology Physician	$759.8K	$0
Myles Mitsunaga	CA	Diagnostic Radiology Physician	$510.8K	$113.9K
Patrick Brown	MD	Dermatology Physician	$586.4K	$0
Hugh Mcswain	CA	Neuroradiology Physician	$235.3K	$292.6K
Abbas Chamsuddin	IL	Diagnostic Radiology Physician	$368.8K	$114.2K
Richard Seefried	VA	Ophthalmology Physician	$472.9K	$0
Scott Marlowe	PA	Diagnostic Ultrasound Physician	$468.7K	$60

Nearby Providers

Other providers in the same ZIP code as Waqas Ilyas, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Grafton School, Inc.	VA	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$92M
Winchester Medical Center	VA	General Acute Care Hospital	$0	$69.9M
Grafton School Inc	VA	Psychiatric Residential Treatment Facility	$0	$33M
Shenandoah Valley Community Residences, Inc.	VA	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$17.4M
Compassionate Home Care	VA	In Home Supportive Care Agency	$0	$14.5M
Nova Family Services, Inc.	VA	Intellectual and/or Developmental Disabilities Residential Treatment Facility	$0	$13.5M
Uncle Sam Transportation LLC	VA	Taxi	$0	$12M
National Counseling Group, Inc	VA	Mental Health Counselor	$0	$11.2M
Pediatrix Medical Group PC	VA	Neonatal-Perinatal Medicine Physician	$0	$10.8M
Winchester Medical Center	VA	Obstetrics & Gynecology Physician	$0	$10M

Waqas Ilyas — Billing Profile & Reimbursement Data

Sign up for Waqas Ilyas — Billing Profile & Reimbursement Data policy alerts

Waqas Ilyas — Billing Profile & Reimbursement Data

Sign up for Waqas Ilyas — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References